NCT06564428View on ClinicalTrials.gov

A Cohort Study of Hereditary Ovarian Cancer Risk Prediction Models and Pathogenesis Exploration

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Ovarian Neoplasms
Interventions
GENETIC

Suspective gene mutations and family history

To observe if the patients with suspective gene mutations or family history take higher risk of suffering from ovarian cancer.

Trial Locations (1)

100000

RECRUITING

Peking University Third Hospital, Beijing

All Listed Sponsors
lead

Peking University Third Hospital

OTHER